Earnings Feed
Start Free
Home/Filings/4/0001171843-15-006650
4//SEC Filing

IMMUNOMEDICS INC 4

Accession 0001171843-15-006650

CIK 0000722830operating
View on SEC.govCompany Profile

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 8:55 PM ET

Size

18.5 KB

Accession

0001171843-15-006650

Insider Transaction Report

Form 4
Period: 2015-12-01
IMMUNOMEDICS INCIMMU
PAETZOLD MARY E
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2015-12-01$1.59/sh+10,000$15,900→ 65,738 total
  • Exercise/Conversion

    Common Stock

    2015-12-01+10,664→ 70,140 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2015-12-01−10,000→ 0 total
    Exercise: $1.59Exp: 2015-12-03→ Common Stock, par value $0.01 per share (10,000 underlying)
  • Award

    Stock Options (right to buy)

    2015-12-02+28,821→ 28,821 total
    Exercise: $3.11Exp: 2022-12-02→ Common Stock, par value $0.01 per share (28,821 underlying)
  • Award

    Restricted Stock Units

    2015-12-02+14,469→ 14,469 total
    → Common Stock, par value $0.01 per share (14,469 underlying)
  • Tax Payment

    Common Stock

    2015-12-01$3.17/sh−6,262$19,851→ 59,476 total
  • Tax Payment

    Common Stock

    2015-12-01−2,666→ 67,474 total
  • Exercise/Conversion

    Restricted Stock Units

    2015-12-01−10,664→ 0 total
    → Common Stock, par value $0.01 per share (10,664 underlying)
Footnotes (4)
  • [F1]Delivery of common stock upon vesting of restricted stock units granted on December 3, 2014.
  • [F2]The number of shares withheld to satisfy the tax withholding obligation of the reporting person upon vesting of Restricted Stock Units is correlated with the reporting person's tax withholding percentage.
  • [F3]The stock options are fully vested on the date of grant.
  • [F4]Each restricted stock unit represents a contingent right to receive one share of Immunomedics, Inc. common stock. The restricted stock units shall vest upon the earlier of (i) the reporting person's completion of one year of service as a non-employee director from the date of grant, or (ii) the reporting person's continuation in service through the day immediately preceding the next annual stockholders meeting following the date of grant.

Documents

1 file

Issuer

IMMUNOMEDICS INC

CIK 0000722830

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000722830

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 8:55 PM ET
Size
18.5 KB
View on SEC.gov